wet AMD

eye eyeball eye art
Biotech

Adverum's gene therapy reduces treatment burden in wet AMD

Adverum’s ixo-vec, a gene therapy for wet AMD, has demonstrated a reduction in treatment burden and maintained visual acuity in a phase 2 study.
Gabrielle Masson Feb 8, 2024 11:17am
very busy graphic of scientists working on an eye with one standing on a ladder preparing drops another set to apply a cont

4DMT links gene therapy to drop in Eylea injections

Feb 5, 2024 6:23am
very busy graphic of scientists working on an eye with one standing on a ladder preparing drops another set to apply a cont

Eyconis launches with $150M and Ascendis' eye disease meds

Jan 29, 2024 11:03am
eye see vision pupil eyelash

Regenxbio-AbbVie in-office gene therapy clears phase 2 test

Jan 17, 2024 9:42am
iris eye eyeball eye art

Kodiak resurrects eye drug after ph. 3 data renew approval plans

Nov 6, 2023 8:40am
eye see vision pupil eyelash

Annexon eye disease med failed phase 2 goal—the CEO is thrilled

May 24, 2023 4:01pm